GENB Generate Biomedicines, Inc.
Nasdaq · SEC CIK 2100782 · EDGAR
- Bought, last 12 months
- $150.30M 6 purchases by 6 insiders
- Sold, last 12 months
- $16.0K 1 sales by 1 insiders
- Filings on record
- 17 since 2026-03-02, latest 2026-09-03 16:05
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Nutritional Health LTP Fund General Partner LLC | 10% | $75.00M | — |
| Flagship Pioneering Fund VI, L.P. | 10% | $75.00M | — |
| Nally Michael | CEO, Dir | $240.0K | — |
| Silvers Jason | Pres, CFO | $32.0K | — |
| Mendillo Jane L | Dir | $24.0K | — |
| ARNOLD FRANCES | Dir | — | $16.0K |
| Grous Beth | CHRO | $4,800 | — |
| Bancel Stephane | Dir | — | — |
Transactions 11
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-03 16:05 | 2026-09-01 | GENB | ARNOLD FRANCES | Dir | S - Sale | $16.00 | -1,000 | 231.5K | -0.4% | -$16.0K |
| 2026-03-06 | 2026-03-04 | GENB | Nally Michael | CEO, Dir | P - Purchase | $12.00 | +20.0K | 572.7K | +4% | +$240.0K | |
| DMI | 2026-03-02 | 2026-03-02 | GENB | Nutritional Health LTP Fund General Partner LLC | 10% | C - Cnv Deriv | — | +32.97M | 2.78M | New | — |
| DMI | 2026-03-02 | 2026-03-02 | GENB | Nutritional Health LTP Fund General Partner LLC | 10% | P - Purchase | $16.00 | +4.69M | 4.34M | New | +$75.00M |
| DMI | 2026-03-02 | 2026-03-02 | GENB | Silvers Jason | Pres, CFO | P - Purchase | $16.00 | +2,000 | 500 | New | +$32.0K |
| D | 2026-03-02 | 2026-03-02 | GENB | Mendillo Jane L | Dir | P - Purchase | $16.00 | +1,500 | 1,500 | New | +$24.0K |
| DMI | 2026-03-02 | 2026-03-02 | GENB | Flagship Pioneering Fund VI, L.P. | 10% | C - Cnv Deriv | — | +32.97M | 13.70M | New | — |
| DMI | 2026-03-02 | 2026-03-02 | GENB | Flagship Pioneering Fund VI, L.P. | 10% | P - Purchase | $16.00 | +4.69M | 15.26M | +44% | +$75.00M |
| DI | 2026-03-02 | 2026-03-02 | GENB | Grous Beth | CHRO | P - Purchase | $16.00 | +300 | 300 | New | +$4,800 |
| DI | 2026-03-02 | 2026-03-02 | GENB | Bancel Stephane | Dir | C - Cnv Deriv | — | +724.2K | 724.2K | New | — |
| DI | 2026-03-02 | 2026-03-02 | GENB | Nally Michael | CEO, Dir | C - Cnv Deriv | — | +658.3K | 1.32M | +100% | — |
Purchase Sale Sale after option exercise All abbreviations